Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors. Read more about Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors.
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma. Read more about Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Exagamglogene Autotemcel for Severe Sickle Cell Disease. Read more about Exagamglogene Autotemcel for Severe Sickle Cell Disease.
Liquefied Petroleum Gas or Biomass Cooking and Severe Infant Pneumonia. Read more about Liquefied Petroleum Gas or Biomass Cooking and Severe Infant Pneumonia.
Effects of Cooking with Liquefied Petroleum Gas or Biomass on Stunting in Infants. Read more about Effects of Cooking with Liquefied Petroleum Gas or Biomass on Stunting in Infants.
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C. Read more about Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C.
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation. Read more about Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation.
Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda. Read more about Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda.
Precision Oncology for Papillary Craniopharyngioma. Read more about Precision Oncology for Papillary Craniopharyngioma.
